• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
Avatrombopag Maleate
BioHub® Magnetic Separator
Avatrombopag
Ursodeoxycholic acid
Troxerutin
CytoLinX® BRTF Single-use Top-driven Bioreactor Bag

Nigeria is working on COVID-19 vaccine, president says

FirstWordPharmaJanuary 07, 2022

Tag: Nigeria , COVID-19 , Vaccine

Nigeria's president says the country is working to develop a COVID-19 vaccine as it battles growing cases of the virus, as reported in the Financial Post.

The West African country has been exploring options to acquire or purchase vaccines through the COVAX facility to enable it to inoculate at least 70% of its population.

It received vaccine donations some of which had a shelf life that left only weeks to administer the shots. Nigeria destroyed more than one million expired vaccines last month.

"We are working very hard with the ministry of health to develop vaccines," said President Muhammadu Buhari, adding "we shouldn't make noise about it until we succeed."

Previous:Imvaq Therapeutics Signs a Service and Commercial Product License to Use ProBioGen’s AGE1.CR® Vaccine Manufacturing Platform

Next:China rushes to develop an mRNA vaccine as doubts grow over local jabs

Related News

Sartorius Stedim Biotech Opens New Center for Bioprocess Innovation in Marlborough, USA

PharmaSourcesNovember 22, 2024

Sartorius Stedim Biotech, a leading partner of the biopharmaceutical industry, today opened its new Center for Bioprocess Innovation in Marlborough, Massachusetts.

BioPharmaSpec Announces Three New Facilities in Freiburg, Bergamo and Vilnius

Biotech NewswireNovember 20, 2024

Rona Therapeutics Presented Positive Phase 1 Results of RN0191, a Novel siRNA Therapy Targeting PCSK9, at the 2024 American Heart Association (AHA) Scientific Sessions

PR NEWSWIRENovember 20, 2024

Nigeria is working on COVID-19 vaccine, president says - PharmaSources.com

AI in Pharmacovigilance: Predicting & Preventing Drug Risks

Nurah EkhlaqueNovember 19, 2024

Discover how AI in pharmacovigilance improves drug safety by predicting risks, identifying harmful interactions, and enhancing patient outcomes.

You may like
More>>

Recombinant Hepatitis B Vaccine(Saccharomyces Cerevisiae)

Recombinant Hepatitis B Vaccine(Saccharomyces Cerevisiae)
H7N9 Inactivated Influenza Vaccine-HUALAN BIO

H7N9 Inactivated Influenza Vaccine-HUALAN BIO
Hualan good immunogenicity performance Influenza Vaccine

Hualan good immunogenicity performance Influenza Vaccine
Influenza Vaccine in Syringe

Influenza Vaccine in Syringe
Quadrivalent Influenza Vaccine, Inactivated (HUALAN BIO)

Quadrivalent Influenza Vaccine, Inactivated (HUALAN BIO)
Cheap Influenza Vaccine

Cheap Influenza Vaccine
Hualan Biological H7N9 Inactivated Influenza Vaccine

Hualan Biological H7N9 Inactivated Influenza Vaccine
Poliomyelitis Vaccine Type I Type III in Dragee Candy (Human Diploid Cell), Live

Poliomyelitis Vaccine Type I Type III in Dragee Candy (Human Diploid Cell), Live
Group ACYW135 Meningococcal Polysaccharide Vaccine

Group ACYW135 Meningococcal Polysaccharide Vaccine

Hualan's Trivalent Flu Vaccine

Hualan's Trivalent Flu Vaccine

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service